Data Collective IV GP, LLC
- SEC CIK
- 0001664974
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 6
- +1 vs. Q3 2022
- Portfolio value
- $95.2M
- −$31.3M (−24.7%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,941,120 | $45.8M | 48.1% | 00.0% | Unchanged | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 10,601,281 | $27.5M | 28.8% | 00.0% | Unchanged | History |
| Rocket Lab USA Inc773122956 | COM | 2,929,350 | $11.0M | 11.6% | 00.0% | Unchanged | – |
| EMBKEmbark Technology, Inc. | COM NEW | 3,186,008 | $10.5M | 11.0% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | COM | 100,350 | $220.8K | 0.2% | −1,404,898−93.3% | Reduced | History |
| ROIVRoivant Sciences Ltd. | SHS | 25,840 | $206.5K | 0.2% | +25,840 | New | History |